Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (31-40 of 450) with videos related to

Pageof 45
Sort By:
Gastroenterology|April 30, 2015
Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?Ruchit Sood, Alexander C Ford
BMJ Clinical Evidence|August 7, 2015
Constipation in adultsMichelle Lau, Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 3, 2009
"Power" of selective serotonin reuptake inhibitors in irritable bowel syndromeAlexander C Ford, Paul Moayyedi
BMJ (Clinical Research Ed.)|August 31, 2013
DyspepsiaAlexander C Ford, Paul Moayyedi
Current Opinion in Gastroenterology|October 9, 2013
DyspepsiaAlexander C Ford, Paul Moayyedi
Handbook of Experimental Pharmacology|December 21, 2016
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic ApproachesMichael Camilleri, Alexander C Ford
Gastroenterology|March 26, 2017
Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From HealthRuchit Sood, Alexander C Ford
BMJ (Clinical Research Ed.)|May 22, 2014
Whom should we "test and treat" for Helicobacter pylori?Alexander C Ford, Paul Moayyedi
Gastroenterology|June 24, 2014
The fall and rise of 5-hydroxytryptamine receptor antagonists in irritable bowel syndrome with diarrheaPavit Luthra, Alexander C Ford
Nature Reviews. Gastroenterology & Hepatology|July 14, 2016
Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Ruchit Sood, Alexander C Ford
Pageof 45

Showing results (31-40 of 450) with videos related to

Sort By:
Pageof 45
Gastroenterology|April 30, 2015
Combining biomarkers in irritable bowel syndrome: a forward step toward making a positive diagnosis and directing therapy?Ruchit Sood, Alexander C Ford
BMJ Clinical Evidence|August 7, 2015
Constipation in adultsMichelle Lau, Alexander C Ford
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 3, 2009
"Power" of selective serotonin reuptake inhibitors in irritable bowel syndromeAlexander C Ford, Paul Moayyedi
BMJ (Clinical Research Ed.)|August 31, 2013
DyspepsiaAlexander C Ford, Paul Moayyedi
Current Opinion in Gastroenterology|October 9, 2013
DyspepsiaAlexander C Ford, Paul Moayyedi
Handbook of Experimental Pharmacology|December 21, 2016
Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic ApproachesMichael Camilleri, Alexander C Ford
Gastroenterology|March 26, 2017
Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From HealthRuchit Sood, Alexander C Ford
BMJ (Clinical Research Ed.)|May 22, 2014
Whom should we "test and treat" for Helicobacter pylori?Alexander C Ford, Paul Moayyedi
Gastroenterology|June 24, 2014
The fall and rise of 5-hydroxytryptamine receptor antagonists in irritable bowel syndrome with diarrheaPavit Luthra, Alexander C Ford
Nature Reviews. Gastroenterology & Hepatology|July 14, 2016
Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same?Ruchit Sood, Alexander C Ford
Pageof 45